We are delighted to announce that Sandra Johnson will join Richmond Pharmacology as its new Director for Commercial Project Management, focused on enhancing the company’s procurement and outsourcing functions.  Sandra joined Richmond Pharmacology in September 2022 from Medicines for Malaria Venture and will work alongside the company’s senior management team and CEO, Dr Jorg Taubel, to improve procurement and outsourcing to further enhance first-in-human and adaptive clinical trials.

Sandra has over 20 years of experience in the life science sector, including at Roche and Novartis, and she has an extensive understanding of clinical procurement. During her time at Medicines for Malaria Venture, she was Director for Outsourcing & Relationship Management. Prior to this, Sandra served as Outsourcing and Procurement Consultant at Minerve Services, and before that as Team Leader Procurement, Global Product Strategy at Roche and Senior CRO Manager at Novartis, where she outsourced clinical research services for Phase I-IV trials and oversaw its strategic outsourcing initiative.

Sandra is currently a member of the Global Health Clinical Consortium and the Pharmaceutical Contracts Management Group (PCMG).

Please join us in welcoming Sandra in our team!

Latest news

Engaging Hearts and Hands: A Day of Volunteering at Arc Nursery

September 12, 2023
Discover how Richmond's dedicated team of volunteers is making a positive impact on young minds at Arc Nursery
Read more

Exciting Research Update: Enhancing Blinding in Clinical Trials with Auto-Injectors

September 5, 2023
We’re excited to share the findings of our recent study on the use of auto-injector systems (A-INJ) in randomized controlled trials (RCTs) by Dr Jorg Taubel, Dr Ulrike Lorch, Dr Thomas York and Vishal Aggarwal.
Read more


BioJapan 2023

11-13 October 2023
BioJapan is "Asia's largest partnering event consisting of Exhibition, Seminar, and Partnering program".
View event